您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > hCAIX/XII-IN-5
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
hCAIX/XII-IN-5
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
hCAIX/XII-IN-5图片
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
hCAIX/XII-IN-5 (Coumarin 9a) 是一种碳酸酐酶 (CA) 抑制剂,并表现出比对 hCA I 和 hCA II 极佳的 hCA IX/XII 选择性 (Ki分别为 93.9 和 85.7 nM)。hCAIX/XII-IN-5 对癌细胞显示出抗增殖活性。hCAIX/XII-IN-5 能延迟细胞周期并诱导细胞的凋亡。
生物活性

hCAIX/XII-IN-5 (Coumarin 9a) acarbonic anhydrase(CA) inhibitor, and exhibits excellent hCA IX/XII selectivity (Ki=93.9 and 85.7 nM, respectively) over hCA I and hCA II. hCAIX/XII-IN-5 shows anti-proliferative activities tocancercells. hCAIX/XII-IN-5 can delay cell cycle and induceapoptosis[1].

IC50& Target

hCA IX

93.9 nM (Ki)

hCA XII

85.7 nM (Ki)

体外研究
(In Vitro)

hCAIX/XII-IN-5 (2.36-32.17 μM) treatment shows both anti-proliferative activities to MCF-7 and PANC-1 cells under the normoxic and hypoxic condition[1].
hCAIX/XII-IN-5 (2.69 μM; 24 h) treatment shows accumulation of MCF-7 cells in the Sub-G1phase and cell arrest in G2-M phase[1].
hCAIX/XII-IN-5 (2.69 μM; 24 h) treatment increases the percent of annexin V-FITC-positive apoptotic cells, including both the early and late apoptotic cells (UR+LR)[1].

Cell Proliferation Assay[1]

Cell Line:MCF-7 and PANC-1 cells
Concentration:2.36-32.17 μM
Incubation Time:
Result:Exerted anti-proliferative activities to MCF-7 and PANC-1 cells (IC50=2.69 μM and 32.17 μM, respectively) under the normoxic condition, and moderate activitits against both MCF-7 and PANC-1 cells (IC50=16.36 μM and 11.78 μM, respectively) under the hypoxic condition.

Cell Cycle Analysis[1]

Cell Line:MCF-7 cells
Concentration:2.69 μM
Incubation Time:24 hours
Result:Resulted in a significant increase in the percentage of cells at Sub-G1by 14-folds with significant increase in cell percentage in the G1-M phase by 2.3-folds compared to the control.

Apoptosis Analysis[1]

Cell Line:MCF-7 cells
Concentration:2.69 μM
Incubation Time:24 hours
Result:Resulted in a significant increase in the percent of annexin V-FITC-positive apoptotic cells, including both the early (from 0.61% to 6.77%) and late apoptotic (from 0.27% to 14.84%) cells (UR+LR), about 11- and 55-fold increase, respectively, as compared with the control.
分子量

291.30

Formula

C18H13NO3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.